AstraZeneca PLC logged a -2.4% change during today's morning session, and is now trading at a price of $69.45 per share. The ...

The government must urgently abolish stamp duty on shares and abolish new cash ISAs to prevent the London Stock Exchange ...

AstraZeneca is reportedly considering moving its listing to the US. Here's why AZN's expected departure is alarming for the ...

Sky's James Sillars writes that a government, struggling for authority and prioritising economic growth, can not afford to ...

AstraZeneca is considering moving its stock market listing from London, where it is the exchange's most valuable company, to ...

AstraZeneca chief executive Sir Pascal Soriot is reportedly considering the move due to growing frustration with the UK's ...

In turn, while the overall impact from them is still yet to be seen, Mr Bailey says tightening rates further could be more ...

The latest international AstraZeneca PLC news and views from Reuters - one of the world's largest news agencies ...

(Reuters) -AstraZeneca is in talks with Summit Therapeutics to license an experimental lung-cancer drug under a deal worth as ...

AstraZeneca, a United Kingdom-headquartered pharmaceutical company, showcases its cutting-edge products and solutions at the sixth China International Import Expo. [Photo/China Daily] ...

This recommendation of Wainzua closely followed that of the Committee for Medicinal Products for Human Use (CHMP) of the European Union for approval by the European Commission, announced by ...